Keith Lamont Cummings - 03 Sep 2021 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Chief Financial Officer
Signature: /s/ Mike Ouimette, attorney-in-fact
Issuer symbol: PLRX
Transactions as of: 03 Sep 2021
Net transactions value: +$41,600
Form type: 4
Filing time: 03 Sep 2021, 18:27:14 UTC
Next filing: 02 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Options Exercise	$41,600	+20,000	+42%	$2.08^*	67,621	03 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (right to buy)	Options Exercise	$0	-20,000	-12%	$0.000000	150,097	03 Sep 2021	Common Stock	20,000	$2.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.